Physician profile
Michael A Buck
NPI 1437166212
$1,866.91
in general payments reported to CMS, 2019-2025
15 companies · $384 in 2025
The $384 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $67.95 · 2021: $596 · 2022: $146 · 2023: $152 · 2024: $411 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $743.84 | 2021-2025 | |
| Abbott Laboratories | $216.67 | 2023-2024 | Proclaim, Eterna |
| Stryker Corporation | $204.61 | 2023-2025 | Limflow System, Ortholoc 2 Lapifuse, Prostep |
| Depuy Synthes Sales INC. | $172.81 | 2024-2025 | Motoband, Na |
| Smith+Nephew, INC. | $170.79 | 2019-2024 | Stravix |
| Organogenesis INC. | $123.33 | 2022-2023 | Puraply |
| Horizon Therapeutics Plc | $49.72 | 2019-2023 | Krystexxa |
| Melinta Therapeutics, LLC | $37.92 | 2021 | |
| Kerecis Limited | $37.50 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Orthofix Medical, INC. | $26.19 | 2020 | |
| Zimmer Biomet Holdings, INC. | $24.32 | 2020 | |
| Hikma Pharmaceuticals USA | $17.74 | 2019 | |
| Conmed Corporation | $15.94 | 2023 | Visiclear |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.45 | 2025 | Jublia, Siliq, Cabtreo |
| Sandoz INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Buck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.